Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2016, Article ID 3239494, 9 pages
http://dx.doi.org/10.1155/2016/3239494
Research Article

A Novel Application of Ti-Substituted Polyoxometalates: Anti-Inflammatory Activity in OVA-Induced Asthma Murine Model

1Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China
2Department of Hepatology, First Hospital of Jilin University, Changchun 130021, China
3College of Veterinary Medicine, Jilin University, Changchun 130062, China
4Key Laboratory of Polyoxometalates Science of Ministry of Education, Faculty of Chemistry, Northeast Normal University, Changchun 130024, China

Received 18 March 2016; Revised 17 May 2016; Accepted 29 May 2016

Academic Editor: Anastasios Keramidas

Copyright © 2016 Dong Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Pope, Y. Jeannin, and M. Fournier, Heteropoly and Isopoly Oxometalates, Springer, Berlin, Germany, 2013.
  2. M. T. Pope and A. Müller, “Polyoxometalate chemistry: an old field with new dimensions in several disciplines,” Angewandte Chemie, vol. 30, no. 1, pp. 34–48, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. G. Chen and J. F. Liu, “Heteropoly complexes containing titanium-I. The complexes with tetrahedral iron or chromium as central atom,” Polyhedron, vol. 15, no. 19, pp. 3433–3436, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-G. Chen, Z. P. Zhu, Y. Y. Zhao, H. D. Wu, S.-Y. Li, and J. F. Liu, “Synthesis and redox properties of undecatungstotitanoheteropoly compounds MnXW11TIO40 center dot xH (2) O (X = Si, B, Zn; M = K, H),” Chinese Journal of Inorganic Chemistry, vol. 15, no. 2, pp. 205–210, 1999. View at Google Scholar
  5. L.-X. Shi, W.-F. Zhao, X. Xu, J. Tang, and C.-D. Wu, “From 1D to 3D single-crystal-to-single-crystal structural transformations based on linear polyanion Mn4H2O18WZnMn2H2O2ZnW9O3424-,” Inorganic Chemistry, vol. 50, no. 24, pp. 12387–12389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. C. W. Baker, V. S. Baker, K. Eriks et al., “A new general structural category of heteropolyelectrolytes. Unusual magnetic and thermal contraction phenomena,” Journal of the American Chemical Society, vol. 88, no. 10, pp. 2329–2331, 1966. View at Publisher · View at Google Scholar · View at Scopus
  7. J. T. Rhule, C. L. Hill, D. A. Judd, and R. F. Schinazi, “Polyoxometalates in medicine,” Chemical Reviews, vol. 98, no. 1, pp. 327–357, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Aureliano, “Decavanadate toxicology and pharmacological activities: V10 or v1, both or none?” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6103457, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Maalaoui, A. Hajsalem, N. Ratel-Ramond, and S. Akriche, “Synthesis, characterization and antibacterial activity of a novel photoluminescent nb-substituted lindqvist polyoxotungstate based organic cation,” Journal of Cluster Science, vol. 25, no. 6, pp. 1525–1539, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Shah, R. Al-Oweini, A. Haider, U. Kortz, and J. Iqbal, “Cytotoxicity and enzyme inhibition studies of polyoxometalates and their chitosan nanoassemblies,” Toxicology Reports, vol. 1, pp. 341–352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Aureliano, C. A. Ohlin, M. O. Vieira, M. P. Marques, W. H. Casey, and L. A. Batista de Carvalho, “Characterization of decavanadate and decaniobate solutions by Raman spectroscopy,” Dalton Transactions, vol. 45, no. 17, pp. 7391–7399, 2016. View at Publisher · View at Google Scholar
  12. T. Yamase, N. Fukuda, and Y. Tajima, “Synergistic effect of polyoxotungstates in combination with β-lactam antibiotics on antibacterial activity against methicillin-resistant Staphylococcus aureus,” Biological and Pharmaceutical Bulletin, vol. 19, no. 3, pp. 459–465, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Fukuda, T. Yamase, and Y. Tajima, “Inhibitory effect of polyoxotungstates on the production of penicillin- binding proteins and β-lactamase against methicillin-resistant Staphylococcus aureus,” Biological and Pharmaceutical Bulletin, vol. 22, no. 5, pp. 463–470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Inoue, T. Suzuki, Y. Fujita, M. Oda, N. Matsumoto, and T. Yamase, “Enhancement of antibacterial activity of β-lactam antibiotics by [P2W18O62]6−, [SiMo12O40]4−, and [PTi2W10O40]7− against methicillin-resistant and vancomycin-resistant Staphylococcus aureus,” Journal of Inorganic Biochemistry, vol. 100, no. 7, pp. 1225–1233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi, and T. Yamase, “Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates,” Antiviral Research, vol. 58, no. 3, pp. 265–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Shigeta, S. Mori, J. Watanabe et al., “In vitro antimyxovirus and anti-human immunodeficiency virus activities of polyoxometalates,” Antiviral Chemistry & Chemotherapy, vol. 6, no. 2, pp. 114–122, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ikeda, S. Nishiya, A. Yamamoto, T. Yamase, C. Nishimura, and E. De Clercq, “Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation,” Journal of Medical Virology, vol. 41, no. 3, pp. 191–195, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Dan and T. Yamase, “Prevention of the interaction between HVEM, herpes virus entry mediator, and gD, HSV envelope protein, by a Keggin polyoxotungstate, PM-19,” Biomedicine and Pharmacotherapy, vol. 60, no. 4, pp. 169–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. S. Braman, “The global burden of asthma,” Chest, vol. 130, no. 1, supplement, pp. 4S–12S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. E. Platts-Mills, “The allergy epidemics: 1870–2010,” Journal of Allergy and Clinical Immunology, vol. 136, no. 1, pp. 3–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Galli, “The mast cell-IgE paradox: from homeostasis to anaphylaxis,” American Journal of Pathology, vol. 186, no. 2, pp. 212–224, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Urb and D. C. Sheppard, “The role of mast cells in the defence against pathogens,” PLoS Pathogens, vol. 8, no. 4, Article ID e1002619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. U. M. Zissler, J. Esser-von Bieren, C. A. Jakwerth, A. M. Chaker, and C. B. Schmidt-Weber, “Current and future biomarkers in allergic asthma,” Allergy, vol. 71, no. 4, pp. 475–494, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Eberl, J. P. Di Santo, and E. Vivier, “The brave new world of innate lymphoid cells,” Nature Immunology, vol. 16, no. 1, pp. 1–5, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Y. Kim, D. T. Umetsu, and R. H. Dekruyff, “Innate lymphoid cells in asthma: will they take your breath away?” European Journal of Immunology, vol. 46, no. 4, pp. 795–806, 2016. View at Publisher · View at Google Scholar
  26. K. F. Chung, “Targeting the interleukin pathway in the treatment of asthma,” The Lancet, vol. 386, no. 9998, pp. 1086–1096, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. C. H. Fanta, “Asthma,” The New England Journal of Medicine, vol. 360, no. 10, pp. 1002–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Domínguez-Ortega, E. Phillips-Anglés, P. Barranco, and S. Quirce, “Cost-effectiveness of asthma therapy: a comprehensive review,” Journal of Asthma, vol. 52, no. 6, pp. 529–537, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Li, R. Guabiraba, A.-G. Besnard et al., “IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice,” Journal of Allergy and Clinical Immunology, vol. 134, no. 6, pp. 1422–1432.e11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. P. N. Pushparaj, D. Li, M. Komai-Koma et al., “Interleukin-33 exacerbates acute colitis via interleukin-4 in mice,” Immunology, vol. 140, no. 1, pp. 70–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Kurowska-Stolarska, B. Stolarski, P. Kewin et al., “IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation,” Journal of Immunology, vol. 183, no. 10, pp. 6469–6477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Stolarski, M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew, “IL-33 exacerbates eosinophil-mediated airway inflammation,” Journal of Immunology, vol. 185, no. 6, pp. 3472–3480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Johnston, M. Zhu, Y. M. Rivera-Sanchez et al., “Allergic airway responses in obese mice,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 7, pp. 650–658, 2007. View at Publisher · View at Google Scholar
  34. N. Pearce, J. Crane, C. Burgess, R. Beasley, and R. Jackson, “Beta-agonists and death from asthma,” The New England Journal of Medicine, vol. 327, no. 5, pp. 355–357, 1992. View at Google Scholar
  35. F. Cerasoli Jr., “Developing the ideal inhaled corticosteroid,” Chest, vol. 130, no. 1, supplement, pp. 54S–64S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. P. Currie, J. G. Douglas, and L. G. Heaney, “Difficult to treat asthma in adults,” British Medical Journal, vol. 338, no. 7694, pp. 593–597, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. T. Holgate, “Stratified approaches to the treatment of asthma,” British Journal of Clinical Pharmacology, vol. 76, no. 2, pp. 277–291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Mitsui, A. Ogata, H. Yanagie et al., “Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24]3H2O, against, human gastric cancer model,” Biomedicine and Pharmacotherapy, vol. 60, no. 7, pp. 353–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. D. L. Barnard, C. L. Hill, T. Gage et al., “Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes,” Antiviral Research, vol. 34, no. 1, pp. 27–37, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Liu, W.-J. Mei, A.-W. Xu, C.-P. Tan, S. Shi, and L.-N. Ji, “Synthesis, characterization and antiviral activity against influenza virus of a series of novel manganese-substituted rare earth borotungstates heteropolyoxometalates,” Antiviral Research, vol. 62, no. 1, pp. 65–71, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. D. E. Katsoulis and M. T. Pope, “New chemistry for heteropolyanions in anhydrous nonpolar solvents. Coordinative unsaturation of surface atoms. Polyanion oxygen carriers,” Journal of the American Chemical Society, vol. 106, no. 9, pp. 2737–2738, 1984. View at Publisher · View at Google Scholar · View at Scopus
  42. D. K. Lyon, W. K. Miller, T. Novet et al., “Highly oxidation resistant inorganic-porphyrin analog polyoxometalate oxidation catalysts. 1. The synthesis and characterization of aqueous-soluble potassium salts of .alpha.2-P2W17O61(Mn+.cntdot.OH2)(n-10) and organic solvent soluble tetra-n-butylammonium salts of .alpha.2-P2W17O61(Mn+.cntdot.Br)(n-11) (M = Mn3+,Fe3+,Co2+,Ni2+,Cu2+),” Journal of the American Chemical Society, vol. 113, no. 19, pp. 7209–7221, 1991. View at Publisher · View at Google Scholar